Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Hepatobiliary/Pancreas

Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: A propensity score matching study

BMC Cancer | Jun 14, 2018 Hepatobiliary/Pancreas

Antiviral therapy in patients with chronic hepatitis C-related hepatocellular carcinoma responding to palliative treatment

Journal of Clinical Gastroenterology | Jun 13, 2018 Hepatobiliary/Pancreas

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): A non-randomised, open-label phase 2 trial

The Lancet Oncology | Jun 12, 2018 Hepatobiliary/Pancreas

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): An open label, non-comparative, phase II trial

BMC Cancer | Jun 12, 2018 Hepatobiliary/Pancreas

Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan

Clinical Epidemiology | Jun 10, 2018 Hepatobiliary/Pancreas

MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer

Carcinogenesis | Jun 08, 2018 Hepatobiliary/Pancreas

IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

BMC Cancer | Jun 08, 2018 Hepatobiliary/Pancreas

Hepatocellular carcinoma outcome is predicted by expression of neuronal calcium sensor 1

Cancer Epidemiology, Biomarkers & Prevention | Jun 08, 2018 Hepatobiliary/Pancreas

Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas

European Journal of Gastroenterology & Hepatology | Jun 07, 2018 Hepatobiliary/Pancreas

Ramucirumab plus pembrolizumab in patients with previously treated advanced or metastatic biliary tract cancer: Nonrandomized, open-label, phase I trial (JVDF)

The Oncologist | Jun 06, 2018 Hepatobiliary/Pancreas

« Prev 1 … 98 99 100 101 102 … 118 Next »

Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: A propensity score matching study

Antiviral therapy in patients with chronic hepatitis C-related hepatocellular carcinoma responding to palliative treatment

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): A non-randomised, open-label phase 2 trial

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): An open label, non-comparative, phase II trial

Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan

MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer

IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

Hepatocellular carcinoma outcome is predicted by expression of neuronal calcium sensor 1

Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas

Ramucirumab plus pembrolizumab in patients with previously treated advanced or metastatic biliary tract cancer: Nonrandomized, open-label, phase I trial (JVDF)

Article: Managing Menopause: Hormone Therapy Myths, Benefits, and Risks

Article on Enhancing Anaesthesiology Workflow through Electronic Medical Records: A Case Study

Article: Sepsis-Associated Acute Kidney Injury (S-AKI) Treatment Essentials

Phage Therapy vs. Superbugs: A Post-Antibiotic Era Solution

Pre-Vodcast Quiz: Test Your Knowledge on HPV Vaccine for Pediatric Care

Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: A propensity score matching study

Antiviral therapy in patients with chronic hepatitis C-related hepatocellular carcinoma responding to palliative treatment

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): A non-randomised, open-label phase 2 trial

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): An open label, non-comparative, phase II trial

Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan

MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer

IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

Hepatocellular carcinoma outcome is predicted by expression of neuronal calcium sensor 1

Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas

Ramucirumab plus pembrolizumab in patients with previously treated advanced or metastatic biliary tract cancer: Nonrandomized, open-label, phase I trial (JVDF)

Article: Managing Menopause: Hormone Therapy Myths, Benefits, and Risks

Article on Enhancing Anaesthesiology Workflow through Electronic Medical Records: A Case Study

Article: Sepsis-Associated Acute Kidney Injury (S-AKI) Treatment Essentials

Phage Therapy vs. Superbugs: A Post-Antibiotic Era Solution

Pre-Vodcast Quiz: Test Your Knowledge on HPV Vaccine for Pediatric Care

Select Specialty

Select Topic